LVTX
LAVA Therapeutics N.V.
Company Overview
| Mkt Cap | $42.35M | Price | $1.63 |
| Volume | 14.88K | Change | -0.31% |
| P/E Ratio | -1.7 | Open | $1.60 |
| Revenue | $12.0M | Prev Close | $1.63 |
| Net Income | $-25.1M | 52W Range | $0.85 - $2.00 |
| Div Yield | N/A | Target | $1.37 |
| Overall | 63 | Value | -- |
| Quality | -- | Technical | 63 |
No chart data available
Stock Overview
Updated DailyLAVA Therapeutics N.V. (LVTX) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $1.63 with a market capitalization of $42.35 million. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows LVTX with a volume of 15K shares. The stock opened down 1.84% from yesterday's close of $1.63. Current analyst estimates project earnings of $-0.84 per share for this year, with next year targeting $-0.53.
LVTX demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for LVTX include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -15.7%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:31 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LVTX | $1.63 | -0.3% | 14.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |